MDL Judge Extends September 2002 Ruling to Proposed Maryland Class Action

NEW YORK - In an order entered March 14, U.S. District Judge Lewis Kaplan denied a motion to certify a proposed class consisting of all Maryland residents who purchased and/or ingested Rezulin based on the court's ruling dated Sept. 12, 2002. In re: Rezulin Products Liability Litigation, MDL No. 1348 (S.D.N.Y.)

Judge Kaplan opined that the proposed class in Lepley (n/k/a Carter) v. Pfizer Inc., No. 24-C-01-005171 (D. Md.) does not 'differ materially' from the classes defined and the claims for which relief was sought by the Plaintiffs' Steering Committee.

In addition to the statewide class, the plaintiffs in Lepley …